2C). mM BME, 0.05 mM BHT, and 0.025% polidocanol). An aqueous emulsion of soybean asolectin (40 mg/ml) and cholesterol (10 mg/ml) was prepared in the reconstitution buffer by sonication, from which a 100 l aliquot was added to 0.9 ml of dialyzed purified RLIP76 protein. After sonication of the resulting mixture for 30 s at 50 W, 200 mg of SM-2 Bio-beads pre-equilibrated with reconstitution buffer (without polidocanol) were added to initiate vesiculation, and after 4 h incubation at 4 C, SM-2 beads were removed by centrifugation at 3000 g and the vesicles (RLIP76-liposomes) were collected. Control-liposomes were prepared using an equal amount of crude protein from not expressing RLIP76. 15 Functional reconstitution of purified kidney cancer cell RLIP76 in artificial liposomes was performed similarly. Transport studies in artificial liposomes Transport studies in proteoliposomes were done by the same method as described previously. No-protein liposomes were used as negative controls. 15 Transport studies in IOVs Inside-out vesicles (IOVs) were prepared from the human kidney cell lines according to the method as described by us for the K562 cells. 15 Transport studies of 14C-DOX, 3H-DNP-SG, 3H-sunitinib and 3H-sorafenib in IOVs were performed by the method as described previously. 15 ATP-dependent uptake of 14C-DOX was determined by subtracting the radio-activity (cpm) of the control without ATP from that of the experimental containing ATP and the transport of DOX was calculated in terms of pmol/min/mg IOV protein. In one of the controls, IOV was excluded while the other control was incubated with an equal amount of heat-inactivated IOV. Each determination was performed in triplicate. The transport of 3H-DNPSG, 3H-sunitinib and Cefprozil hydrate (Cefzil) 3H-sorafenib were measured in a similar manner. Transport studies in vesicles coated with antibodies ATP-dependent transport of 14C-DOX, 3H-DNP-SG, 3H-sunitinib and 3H-sorafenib in IOVs or purified reconstituted liposomes, coated with different antibodies was measured as described previously. 17 Briefly, either IOV or purified reconstituted liposomes (20 g or 0.25 g protein/30 l reaction mixture, respectively) were incubated separately with I g of each anti-RLIP76, anti-MRP1, and anti-Pgp antibodies for 30 min at room temperature. In one of the controls, IgG was excluded while the other control was treated with an equal amount of pre-immune IgG. After incubation, the ATP-dependent transport of 14C-DOX, 3H-DNP-SG, 3H-sunitinib and 3H-sorafenib were measured. Drug-sensitivity assay Cell density measurements were performed using a hemocytometer to count reproductive cells resistant to staining with trypan blue. Approximately 20,000 cells were seeded into each well of 96-well plates containing 160 l medium. Post 24 h incubation, 40 l aliquots of drug concentrations ranging from 0.1 M to 100 M was then added to eight replicate wells to assess the IC50 of drug. After 96 h incubation, 20 l of 5 mg/ml MTT was introduced to each well and incubated for 2 h. The plates were centrifuged and cells were subsequently dissolved in 100 l DMSO with gentle shaking for 2 h at ZNF35 room temperature, followed by measurement of OD at 570 nm. Inhibition of RLIP76 expression in cells by RLIP76 antibodies were measured by Cefprozil hydrate (Cefzil) incubating the cells with RLIP76 antibodies (40 g/ml final conc.) for 24 h prior to MTT assay. Depletion of RLIP76 expression in cells by RLIP76 siRNA and RLIP76 antisense were measured as follows: cells were incubated for 3 h with either RLIP76 siRNA (20 g/ml final conc.) or RLIP76 anti-sense (10 g/ml final conc.) in Transmessenger Transfection Reagent (Qiagen) or Maxfect transfection reagent (MoleculA), respectively, according to the manufacturer provided protocol. Cells were.Therefore, the sensitivity of kidney cancer cells towards DOX, sorafenib, sunitinib and temsirolimus were compared using an MTT assay (Fig. mM KCl, 40 mM sucrose, 2.8 mM BME, 0.05 mM BHT, and 0.025% polidocanol). An aqueous emulsion of soybean asolectin (40 mg/ml) and cholesterol (10 mg/ml) was prepared in the reconstitution buffer by sonication, from which a 100 l aliquot was added to 0.9 ml of dialyzed purified RLIP76 protein. After sonication of the resulting mixture for 30 s at 50 W, 200 mg of SM-2 Bio-beads pre-equilibrated with reconstitution buffer (without polidocanol) were added to initiate vesiculation, and after 4 h incubation at 4 C, SM-2 beads were removed by centrifugation at 3000 g and the vesicles (RLIP76-liposomes) were collected. Control-liposomes were prepared using an equal amount of crude protein from not expressing RLIP76. Cefprozil hydrate (Cefzil) 15 Functional reconstitution of purified Cefprozil hydrate (Cefzil) kidney cancer cell RLIP76 in artificial liposomes was performed similarly. Transport studies in artificial liposomes Transport studies in proteoliposomes were done by the same method as described previously. No-protein liposomes were used as negative controls. 15 Transport studies in IOVs Inside-out vesicles (IOVs) were prepared from the human kidney cell lines according to the method as described by us for the K562 cells. 15 Transport studies of 14C-DOX, 3H-DNP-SG, 3H-sunitinib and 3H-sorafenib in IOVs were performed by the method as described previously. 15 ATP-dependent uptake of 14C-DOX was determined by subtracting the radio-activity (cpm) of the control without ATP from that of the experimental containing ATP and the transport of DOX was calculated in terms of pmol/min/mg IOV protein. In one of the controls, IOV was excluded while the other control was incubated with an equal amount of heat-inactivated IOV. Each determination was performed in triplicate. The transport of 3H-DNPSG, 3H-sunitinib and 3H-sorafenib were measured in a similar manner. Transport studies in vesicles coated with antibodies ATP-dependent transport of 14C-DOX, 3H-DNP-SG, 3H-sunitinib and 3H-sorafenib in IOVs or purified reconstituted liposomes, coated with different antibodies was measured as described previously. 17 Briefly, either IOV or purified reconstituted liposomes (20 g or 0.25 g protein/30 l reaction mixture, respectively) were incubated separately with I g of each anti-RLIP76, anti-MRP1, and anti-Pgp antibodies for 30 min at room temperature. In one of the controls, IgG was excluded while the other control was treated with an equal amount of pre-immune IgG. After incubation, the ATP-dependent transport of 14C-DOX, 3H-DNP-SG, 3H-sunitinib and 3H-sorafenib were measured. Drug-sensitivity assay Cell density measurements were performed using a hemocytometer to count reproductive cells resistant to staining with trypan blue. Approximately 20,000 cells were seeded into each well of 96-well plates containing 160 l medium. Post 24 h incubation, 40 l aliquots of drug concentrations ranging from 0.1 M to 100 M was then added to eight replicate wells to assess the IC50 of drug. After 96 h incubation, 20 l of 5 mg/ml MTT was introduced to each well and incubated for 2 h. The plates were centrifuged and cells were subsequently dissolved in 100 l DMSO with gentle shaking for 2 h at room temperature, followed by measurement of OD at 570 nm. Inhibition of RLIP76 expression in cells by RLIP76 antibodies were measured by incubating the cells with RLIP76 antibodies (40 g/ml final conc.) for 24 h prior to MTT assay. Depletion of RLIP76 expression in cells by RLIP76 siRNA and RLIP76 antisense were measured as follows: cells were incubated for 3 h with either RLIP76 siRNA (20 g/ml final conc.) or RLIP76 anti-sense (10 g/ml final conc.) in Transmessenger Transfection Reagent (Qiagen) or Maxfect transfection reagent (MoleculA), respectively, according to the manufacturer provided protocol. Cells were then washed with PBS, followed by 48 h incubation at 37 C in medium before MTT assay. 8, 13, 14 Colorimetric assay for the detection of total ERK1/2, phospho-ERK1/2, total PI3K and phospho-PI3K Kidney cancer cells were seeded in 96 well plate (~50, 000 cells per well) and treated with 20 M sunitinib, sorafenib and temsirolimus, and RLIP76 antisense (10 g/ml final conc.) for 24h and were fixed with 4% formaldehyde in PBS for 20 minutes at room temperature followed by washing with wash buffer. The vendor-provided method was used to determine total and phosphorylated proteins using phospho-specific antibodies (Active Motif). Colony forming assay Cells (0.1 106 cells / 500 l) were irradiated at 100, 200, 500 and 1000 cGY (6 106 volt-photon/min) for 1.25 min at the Texas Cancer Center,.